Murrieta Genomics has announced that its wholly owned subsidiary, SimplSeq Inc., has filed a new patent application for simplified sample
Blog
Murrieta Genomics has partnered with Life Science Nation (LSN) and the RESI (Redefining Early Stage Investments) Conference to offer startup
The RuleOut team has created a novel approach that can exponentially increase COVID-19 testing capacity.
Murrieta Genomics and SimplSeq to Participate in Life Science Nation's Digital RESI Partnering Event
Life Science Nation provides an incredibly important service to early stage life science companies by connecting them with products, services
Press Releases
“The simplSEQ workflow offers many workflow advantages over other methods of cell-free DNA extraction especially speed, simplicity, reproducibility, which are
Company Filed Second Patent Application to Extend Core Technology Applications
Murrieta Genomics is pleased to announce that U.S. Patent and Trademark
Murrieta Genomics, the launch pad for genomic sequencing startups, is pleased to announce that simplSEQ, an incubator company and subsidiary,
“Our first product is a kit for the purification and isolation of nucleic acids from plasma that we believe will
University of California
The University of California system has four campuses within a close drive from Murrieta Genomics. We are actively working with the Riverside, San Diego and Los Angeles campuses, and will be providing more information on intellectual property in the near future.
George Washington University,
More information coming soon, this space will contain information about the products or services that your company provides, this space will contain information about the products or services that your company provides.
University of Colorado
More information coming soon, this space will contain information about the products or services that your company provides, this space will contain information about the products or services that your company provides.